Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

COMPASS Pathways plc (CMPS) Financial Statements

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CMPSCOMPASS Pathways plcFollow CMPS — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
1.5B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
2 Nov, in 9 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.

LineFY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Research & development23.444.065.187.5119.0118.4112.9
Operating income-51.4-83.2-110.4-136.9-178.2-179.0-181.8
Pre-tax income-60.3-71.5-91.1-117.7-153.5-290.3-396.8
Income tax0.00.20.40.81.6-2.5-2.6
Net income-60.3-71.7-91.5-118.5-155.1-287.9-394.2
Diluted EPS ($)-3.55-1.79-2.16-2.32-2.30-3.08-3.88
Diluted shares (mn)—40.042.451.067.593.5—

USD millions · SEC XBRL

COMPASS Pathways plc — questions

What is COMPASS Pathways plc's net income?
-$394.2M over the twelve months to 2026-06-30.
What are COMPASS Pathways plc's diluted earnings per share?
$-3.88 over the twelve months to 2026-06-30.

Every figure on this page comes from COMPASS Pathways plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.